Lazzaroni, Maria-Grazia http://orcid.org/0000-0002-1860-6866
Piantoni, Silvia http://orcid.org/0000-0003-0913-0197
Angeli, Fabrizio http://orcid.org/0000-0002-5990-2979
Bertocchi, Stefania http://orcid.org/0000-0002-5798-8254
Franceschini, Franco http://orcid.org/0000-0003-3678-6124
Airò, Paolo http://orcid.org/0000-0001-5241-1918
Article History
Accepted: 31 January 2022
First Online: 7 March 2022
Change Date: 23 July 2022
Change Type: Update
Change Details: The original version of this paper was updated to present the missing Open Access funding note.
Declarations
:
: Dr. Paolo Airò reports receiving personal fees from Bristol Myers Squibb and from Boehringer Ingelheim, and non-financial support from CSL Behring, SOBI, Janssen, Roche, and Sanofi. Personal fees include speakers bureau, consultancy (< 2000 EURO); non-financial support includes travel expenses (< 1000 EURO). No other potential conflict of interest relevant to this article was reported.